Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback